Early-Stage Breast Cancer Not Yet Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

IndicationStatusPhase
DBCOND0031560 (Early-Stage Breast Cancer)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03894007Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast CancerTreatment